KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $2.5 billion.

  • Evolent Health's Liabilities and Shareholders Equity fell 193.08% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 billion, marking a year-over-year decrease of 182.51%. This contributed to the annual value of $2.5 billion for FY2024, which is 507.02% down from last year.
  • According to the latest figures from Q3 2025, Evolent Health's Liabilities and Shareholders Equity is $2.5 billion, which was down 193.08% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Liabilities and Shareholders Equity registered a high of $2.7 billion during Q4 2023, and its lowest value of $1.3 billion during Q3 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $2.5 billion (2025), whereas its average is $2.1 billion.
  • In the last 5 years, Evolent Health's Liabilities and Shareholders Equity crashed by 1000.65% in 2021 and then skyrocketed by 10299.15% in 2023.
  • Evolent Health's Liabilities and Shareholders Equity (Quarter) stood at $1.4 billion in 2021, then rose by 28.03% to $1.8 billion in 2022, then surged by 47.49% to $2.7 billion in 2023, then fell by 5.07% to $2.5 billion in 2024, then decreased by 3.57% to $2.5 billion in 2025.
  • Its Liabilities and Shareholders Equity was $2.5 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.7 billion in Q1 2025.